Intrinsic Value of S&P & Nasdaq Contact Us

Nuvation Bio Inc. NUVB

NYSE

SharesGrow Score
55/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$12.40
+155.7%

Nuvation Bio Inc. (NUVB) current share price is $4.85. The gold spot price is $4,825.20 per troy ounce. Using the formula: NUVB in gold = $4.85 × 31.1035 ÷ $4,825.20 = 0.0313 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of NUVB when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding NUVB shares over the measured period.

NUVB in US Dollars
Gold in US Dollars
NUVB in Gold (grams per share)

Real Wealth Growth Rate

NUVB
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{NUVB}_{\text{gold}}(t) = \frac{P_{\text{NUVB}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{NUVB}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{NUVB}_{\text{gold}}^{(T)}}{\text{NUVB}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{NUVB}_\text{gold}^{(0)}$ = initial gold-price, $\text{NUVB}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.16
-2.01%
VERA
VERA
Vera Therapeutics, Inc.
$44.36
+1.49%
GPCR
GPCR
Structure Therapeutics Inc.
$53.19
-1.95%
CLDX
CLDX
Celldex Therapeutics, Inc.
$33.33
+2.27%
AUPH
AUPH
Aurinia Pharmaceuticals Inc.
$16.07
+0.06%
OCUL
OCUL
Ocular Therapeutix, Inc.
$8.76
-1.13%
VRDN
VRDN
Viridian Therapeutics, Inc.
$15.19
+2.64%
ABCL
ABCL
AbCellera Biologics Inc.
$3.76
+2.73%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message